ORIGINAL RESEARCH
Published on 01 Aug 2025
L1, a 3,3′-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells
doi 10.3389/fphar.2025.1564199
- 1,142 views
- Frontiers in Medicine
- Gene and Cell Therapy
- Research Topics
- Exploiting Biomarkers for Targeted Therapies in Acute Myeloid Leukemia
Exploiting Biomarkers for Targeted Therapies in Acute Myeloid Leukemia
2,567
Total downloads
11k
Total views and downloads
Articles
REVIEW
Published on 14 May 2025
Drug-tolerant persister cells in acute myeloid leukemia: pressing challenge and promising new strategies for treatment
doi 10.3389/fmed.2025.1586552
- 2,447 views
ORIGINAL RESEARCH
Published on 21 Mar 2025
Identifying acute myeloid leukemia subtypes based on pathway enrichment
doi 10.3389/fphar.2025.1557112
- 2,204 views
- 1 citation
ORIGINAL RESEARCH
Published on 28 Feb 2024
A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia
doi 10.3389/fphar.2024.1339465
- 2,899 views
- 3 citations
Published in
Frontiers in Medicine
Gene and Cell Therapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore